Polaris Group — Investor Relations & Filings
Polaris Group is a biotechnology company dedicated to the development of novel anti-cancer therapies and the provision of Contract Development and Manufacturing Organization (CDMO) services. The company’s core research focuses on ADI-PEG 20 (pegargiminase), a biological agent that utilizes metabolic therapy to target arginine-dependent cancers. This candidate is currently in late-stage clinical development for multiple indications, including mesothelioma, soft tissue sarcoma, and hepatocellular carcinoma. Polaris Group maintains a vertically integrated business model, encompassing drug design, clinical trial management, and internal manufacturing capabilities. It operates cGMP-compliant facilities and has expanded its CDMO portfolio to include complex injectables and synthetic peptides. The company aims to deliver innovative treatment options by leveraging its proprietary technology and global clinical partnerships.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公告本公司董事會通過115年股東常會召開相關事宜(新增議案) | 2026-03-30 | Chinese |
Browse filings by year
1 year| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 33152742 | 公告本公司董事會通過115年股東常會召開相關事宜(新增議案) | 2026-03-30 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Polaris Group via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52582/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52582 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52582 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52582 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52582}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Polaris Group (id: 52582)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.